Avidity Biosciences
Stock Forecast, Prediction & Price Target
Avidity Biosciences Financial Estimates
Avidity Biosciences Revenue Estimates
Avidity Biosciences EBITDA Estimates
Avidity Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $9.32M N/A | $9.22M -1.09% | $9.56M 3.64% | Avg: $12.13M Low: $10.49M High: $13.77M avg. 26.96% | Avg: $84.51M Low: $77.18M High: $91.83M avg. 596.32% | Avg: $362.55M Low: $331.07M High: $393.95M avg. 328.95% | Avg: $828.92M Low: $756.95M High: $900.72M avg. 128.63% |
Net Income
% change YoY
| $-117.37M N/A | $-169.07M -44.05% | $-212.22M -25.51% | Avg: $-341.46M Low: $-320.52M High: $-165.73M avg. -60.89% | Avg: $-318.87M Low: $-322.71M High: $-75.93M avg. 6.61% | Avg: $-109.15M Low: $-121.44M High: $-96.83M avg. 65.76% | Avg: $162.45M Low: $144.11M High: $180.74M avg. 248.82% |
EBITDA
% change YoY
| $-118.05M N/A | $-178.91M -51.55% | $-233.49M -30.50% | Avg: $-12.13M Low: $-13.77M High: $-10.49M avg. 94.80% | Avg: $-84.51M Low: $-91.83M High: $-77.18M avg. -596.32% | Avg: $-362.55M Low: $-393.95M High: $-331.07M avg. -328.95% | Avg: $-828.92M Low: $-900.72M High: $-756.95M avg. -128.63% |
EPS
% change YoY
| -$2.83 N/A | -$3.24 -14.48% | -$2.91 10.18% | Avg: -$3.45 Low: -$4.39 High: -$2.27 avg. -18.68% | Avg: -$3.21 Low: -$4.42 High: -$1.04 avg. 7.05% | Avg: -$1.5 Low: -$1.66 High: -$1.33 avg. 53.42% | Avg: $2.23 Low: $1.97 High: $2.48 avg. 248.82% |
Operating Expenses
% change YoY
| $127.37M N/A | $188.13M 47.70% | $245.15M 30.30% | Avg: $40.14M Low: $34.69M High: $45.57M avg. -83.62% | Avg: $279.52M Low: $255.25M High: $303.73M avg. 596.32% | Avg: $1.19B Low: $1.09B High: $1.30B avg. 328.95% | Avg: $2.74B Low: $2.50B High: $2.97B avg. 128.63% |
FAQ
What is Avidity Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 65.07% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -320.52M, average is -341.46M and high is -165.73M.
What is Avidity Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 270.22% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $10.49M, average is $12.13M and high is $13.77M.
What is Avidity Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 72.65% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.39, average is -$3.45 and high is $-2.27.
What is the best performing analyst?
In the last twelve months analysts have been covering Avidity Biosciences stock. The most successful analyst is Yanan Zhu.